Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmos Pharmaceutical Corp
TSE:3349
|
JP |
|
Persimmon PLC
F:OHP0
|
UK |
|
A
|
ABOUT YOU Holding SE
DUS:YOU
|
DE |
|
U
|
UGI Corp
F:3U6
|
US |
|
Forestar Group Inc
NYSE:FOR
|
US |
|
K
|
Kingfisher PLC
SWB:KFI1
|
UK |
|
Charter Communications Inc
NASDAQ:CHTR
|
US |
|
S
|
Stanley Black & Decker Inc
SWB:SWF
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
B
|
BAE Systems PLC
F:BSP
|
UK |
|
F
|
First Majestic Silver Corp
F:FMV
|
CA |
|
L
|
Logan Energy Corp
OTC:LOECF
|
CA |
|
L
|
LSI Industries Inc
F:LS2
|
US |
|
Note AB (publ)
STO:NOTE
|
SE |
Wall St Price Targets
Price Targets Summary
Cosmos Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 8 730.27 JPY with a low forecast of 6 363 JPY and a high forecast of 11 445 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cosmos Pharmaceutical Corp's stock price target?
Price Target
8 730.27
JPY
According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 8 730.27 JPY with a low forecast of 6 363 JPY and a high forecast of 11 445 JPY.
What is the Revenue forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 10%.
What is the Pre-Tax Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.
